Cumhurba\u015fkanl\u0131\u011f\u0131 Sa\u011fl\u0131k Dan\u0131\u015fman\u0131 Prof. Dr. Nedime Serak\u0131nc\u0131, meme kanserinin kad\u0131nlarda g\u00f6r\u00fclen kanserler aras\u0131nda ilk s\u0131rada oldu\u011funu belirterek, \u201c\u00c7evresel fakt\u00f6rleri ve ya\u015fam al\u0131\u015fkanl\u0131klar\u0131n\u0131 de\u011fi\u015ftirerek kanserden y\u00fczde 90-95 oran\u0131nda korunmak m\u00fcmk\u00fcnd\u00fcr.\u201d dedi.<\/p>\n
Serak\u0131nc\u0131, 1-31 Ekim Meme Kanseri Bilin\u00e7lendirme ve Fark\u0131ndal\u0131k Ay\u0131 kapsam\u0131nda T\u00fcrk Ajans\u0131 K\u0131br\u0131s\u2019a (TAK) a\u00e7\u0131klamada bulunarak, meme kanserinde erken tan\u0131, genetik testler, risk fakt\u00f6rleri ve ki\u015fiye \u00f6zel yeni tedavi y\u00f6ntemlerine ili\u015fkin bilgi verdi.<\/p>\n
-\u201cD\u00fcnya genelinde 50-70 ya\u015f aras\u0131nda, b\u00f6lgemizde ise 40-49 ya\u015f aral\u0131\u011f\u0131nda\u201d<\/p>\n
Meme kanserinin hem kad\u0131nlarda hem de erkeklerde g\u00f6r\u00fclebildi\u011fini ancak vakalar\u0131n y\u00fczde 99’unun kad\u0131n oldu\u011funu kaydeden Serak\u0131nc\u0131, “kad\u0131n olmak en temel risk fakt\u00f6r\u00fcd\u00fcr” dedi. <\/p>\n
Ya\u015f ilerledik\u00e7e g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 ifade eden Serak\u0131nc\u0131, d\u00fcnya genelinde vakalar\u0131n 50-70 ya\u015f aras\u0131nda yo\u011funla\u015ft\u0131\u011f\u0131n\u0131, ancak T\u00fcrkiye ve b\u00f6lgedeki akademik \u00e7al\u0131\u015fmalar\u0131n bu ya\u015f aral\u0131\u011f\u0131n\u0131n 40-49\u2019a kadar geriledi\u011fini g\u00f6sterdi\u011fini kaydetti.<\/p>\n
-\u201c\u00c7evresel fakt\u00f6rleri de\u011fi\u015ftirerek korunmak m\u00fcmk\u00fcn\u201d<\/p>\n
Meme kanserinin yaln\u0131zca y\u00fczde 5 ila 10’unun kal\u0131tsal (genetik) mutasyonlardan kaynakland\u0131\u011f\u0131n\u0131 alt\u0131n\u0131 \u00e7izen Serak\u0131nc\u0131, \u201cGenetik yatk\u0131nl\u0131\u011fa sahip olmak kader de\u011fil. \u00c7evresel fakt\u00f6rleri ve ya\u015fam al\u0131\u015fkanl\u0131klar\u0131n\u0131 de\u011fi\u015ftirerek kanserden y\u00fczde 90-95 oran\u0131nda korunmak m\u00fcmk\u00fcnd\u00fcr.\u201d dedi.<\/p>\n
Serak\u0131nc\u0131, obezite, sigara ve alkol kullan\u0131m\u0131, hareketsiz ya\u015fam, uzun s\u00fcreli hormona maruz kalma ve radyasyonun ba\u015fl\u0131ca risk fakt\u00f6rleri oldu\u011funu belirterek, kilo kontrol\u00fc, sa\u011fl\u0131kl\u0131 beslenme ve d\u00fczenli fiziksel aktivitenin kanser riskini azaltmada en etkili y\u00f6ntemler oldu\u011funu vurgulad\u0131.<\/p>\n
-\u201cTek bir nedene ba\u011flayamay\u0131z\u201d<\/p>\n
Bir\u00e7ok kanser t\u00fcr\u00fcnde oldu\u011fu gibi meme kanserinde de tek bir neden g\u00f6sterilemeyece\u011fini s\u00f6yleyen Prof. Dr. Serak\u0131nc\u0131, hastal\u0131\u011f\u0131n genetik, hormonal ve \u00e7evresel fakt\u00f6rlerin bir araya gelmesiyle geli\u015fti\u011fini belirtti.<\/p>\n
Uzun s\u00fcre \u00f6strojen ve progesteron hormonuna maruz kalman\u0131n riski art\u0131rd\u0131\u011f\u0131na dikkat \u00e7eken Serak\u0131nc\u0131, erken adet g\u00f6rme, menopoza ge\u00e7 girme ve do\u011fum yapmaman\u0131n hormonal risk fakt\u00f6rleri aras\u0131nda yer ald\u0131\u011f\u0131n\u0131 ifade etti.<\/p>\n
-\u201c\u0130leri evre kanserler dahi kontrol alt\u0131na al\u0131nabiliyor\u201d<\/p>\n
T\u0131ptaki geli\u015fmelerle birlikte ki\u015fiye \u00f6zel ve hedefe y\u00f6nelik tedavilerin devreye girdi\u011fini, genetik tan\u0131 sayesinde kanserli dokuya \u00f6zel \u00e7\u00f6z\u00fcmler \u00fcretildi\u011fini anlatan Serak\u0131nc\u0131, bu sayede ileri evre hastalar\u0131nda dahi kanserin kronik bir hastal\u0131k gibi kontrol alt\u0131nda tutulabildi\u011fini, ya\u015fam s\u00fcresinin uzad\u0131\u011f\u0131n\u0131 kaydetti.<\/p>\n
-\u201cHerkes genetik test yapt\u0131rmamal\u0131\u201d<\/p>\n
Kanser taramas\u0131na y\u00f6nelik genetik testlerin toplumdaki her birey i\u00e7in rutin bir uygulama olmad\u0131\u011f\u0131n\u0131 da vurgulayan Serak\u0131nc\u0131, rastgele yap\u0131lan testlerin kafa kar\u0131\u015f\u0131kl\u0131\u011f\u0131na ve gereksiz kayg\u0131ya yol a\u00e7abilece\u011fi uyar\u0131s\u0131nda bulundu.<\/p>\n
Nedime Serak\u0131nc\u0131, genetik testlerin, ailesinde gen\u00e7 ya\u015fta veya birden fazla ki\u015fide kanser \u00f6yk\u00fcs\u00fc bulunanlara, erkeklerde meme kanseri gibi nadir vakalara ve doktoru taraf\u0131ndan ak\u0131ll\u0131 ila\u00e7 tedavisi uygun g\u00f6r\u00fclen hastalara yap\u0131lmas\u0131 gerekti\u011fini belirtti. <\/p>\n<\/p>\n
\u00a0<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"
Cumhurba\u015fkanl\u0131\u011f\u0131 Sa\u011fl\u0131k Dan\u0131\u015fman\u0131 Prof. Dr. Nedime Serak\u0131nc\u0131, meme kanserinin kad\u0131nlarda g\u00f6r\u00fclen kanserler aras\u0131nda ilk s\u0131rada oldu\u011funu belirterek, \u201c\u00c7evresel fakt\u00f6rleri ve ya\u015fam al\u0131\u015fkanl\u0131klar\u0131n\u0131 de\u011fi\u015ftirerek kanserden y\u00fczde 90-95 oran\u0131nda korunmak m\u00fcmk\u00fcnd\u00fcr.\u201d dedi. Serak\u0131nc\u0131, 1-31 Ekim Meme Kanseri Bilin\u00e7lendirme ve Fark\u0131ndal\u0131k Ay\u0131 kapsam\u0131nda T\u00fcrk Ajans\u0131 K\u0131br\u0131s\u2019a (TAK) a\u00e7\u0131klamada bulunarak, meme kanserinde erken tan\u0131, genetik testler, risk fakt\u00f6rleri ve …<\/p>\n","protected":false},"author":1,"featured_media":162321,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[50868,50869,895,50867,1012,9422,19208,12971],"class_list":["post-162320","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kibris","tag-40-49","tag-araligina","tag-geriledi","tag-gorulme","tag-kanseri","tag-meme","tag-serakinci","tag-yasi"],"_links":{"self":[{"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/posts\/162320"}],"collection":[{"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/comments?post=162320"}],"version-history":[{"count":0,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/posts\/162320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/media\/162321"}],"wp:attachment":[{"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/media?parent=162320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/categories?post=162320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kibrishost.com\/tak\/wp-json\/wp\/v2\/tags?post=162320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}